News
Non-Ribosomal Peptide Antibiotics Dominated the Market with USD 1.4 Billion Valuation in 2024 Due to Enhanced EfficacyDublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Peptide Antibiotics Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback